Gary Vanasse
Impact in
- Hematology top 5%
- Iron Metabolism and Disorders
- Chronic Myeloid Leukemia Treatments
- Erythropoietin and Anemia Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 14
- Chronic Myeloid Leukemia Treatments 5
- Erythropoietin and Anemia Treatment 4
- Genetics 11
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Chronic Lymphocytic Leukemia Research 4
- Co-authors
- Nancy Berliner (5 shared papers)Dennis M. Willerford (4 shared papers)Patrick Concannon (2 shared papers)Reena L. Pande (1 shared paper)Todd S. Perlstein (1 shared paper)Christine M. Distèche (2 shared papers)Xiaomei Ma (1 shared paper)Matthew S. Freiberg (3 shared papers)
- Journals
- Blood (5 papers)British Journal of Haematology (3 papers)Cancer Research (3 papers)HemaSphere (2 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Gary Vanasse
32 papers receiving 826 citations
Peers
Comparison fields: 5 of 84
- Hematology 268
- Genetics 215
- Emergency Medicine 101
- Virology 42
- Pathology and Forensic Medicine 115
Countries citing papers authored by Gary Vanasse
This map shows the geographic impact of Gary Vanasse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Vanasse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Vanasse more than expected).
Fields of papers citing papers by Gary Vanasse
This network shows the impact of papers produced by Gary Vanasse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Vanasse. The network helps show where Gary Vanasse may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Vanasse, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 166 | |
| 2 | 1999 | 97 | |
| 3 | 2011 | 95 | |
| 4 | 1999 | 84 | |
| 5 | 2010 | 80 | |
| 6 | 2008 | 70 | |
| 7 | 2015 | 21 | |
| 8 | 2004 | 18 | |
| 9 | 2011 | 18 | |
| 10 | 2002 | 17 | |
| 11 | 1990 | 16 | |
| 12 | 2007 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2006 | 15 | |
| 15 | 2021 | 14 | |
| 16 | 2011 | 13 | |
| 17 | 2019 | 13 | |
| 18 | 2013 | 12 | |
| 19 | 1990 | 12 | |
| 20 | 1991 | 11 |
About Gary Vanasse
Gary Vanasse is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Molecular Biology and Oncology, having authored 32 papers that have together received 846 indexed citations. Recurring topics across this work include Erythrocyte Function and Pathophysiology (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), Click Chemistry and Applications (4 papers), Erythropoietin and Anemia Treatment (4 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer Mechanisms and Therapy (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (268 citations), Genetics (215 citations), Emergency Medicine (101 citations), Virology (42 citations) and Pathology and Forensic Medicine (115 citations). Gary Vanasse has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Nancy Berliner, Dennis M. Willerford, Patrick Concannon, Reena L. Pande, Todd S. Perlstein, Christine M. Distèche, Xiaomei Ma, Matthew S. Freiberg, Yun Wang and Brenda Cartmel. Their work appears in journals such as Blood, British Journal of Haematology, Cancer Research, HemaSphere and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.